These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

96 related articles for article (PubMed ID: 15756665)

  • 21. In vivo studies on toxin accumulation in liver and ultrastructural changes of hepatocytes of the phytoplanktivorous bighead carp i.p.-injected with extracted microcystins.
    Li L; Xie P; Chen J
    Toxicon; 2005 Oct; 46(5):533-45. PubMed ID: 16084552
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Hemodynamic and morphologic changes of peripheral hepatic vasculature in chronic liver disease: a preliminary study by contrast-enhanced coded phase-inversion harmonic sonography.
    Sakaguchi Y; Kudo M; Zheng RQ; Chung H; Minami Y; Ogawa C; Kitano M; Kawasaki T; Maekawa K
    J Med Ultrason (2001); 2005 Dec; 32(4):197-204. PubMed ID: 27277489
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Liver mass evaluation with ultrasound: the impact of microbubble contrast agents and pulse inversion imaging.
    Wilson SR; Burns PN
    Semin Liver Dis; 2001 May; 21(2):147-59. PubMed ID: 11436569
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Influence of Microbubble Size and Pulse Amplitude on Hepatocyte Injury Induced by Contrast-Enhanced Diagnostic Ultrasound.
    Miller DL; Lu X; Fabiilli M; Dou C
    Ultrasound Med Biol; 2019 Jan; 45(1):170-176. PubMed ID: 30366606
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Evaluation of enhancement patterns of focal nodular hyperplasia in contrast-enhanced, wide-band phase-inversion harmonic power Doppler imaging of the liver.
    Janica J; Serwatka W; Polaków J; Ustymowicz A; Walecki J; Ladny JR; Dobrzycki S
    Med Sci Monit; 2004 Jun; 10 Suppl 3():17-21. PubMed ID: 16538193
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Comparison of contrast-enhanced fundamental imaging, second-harmonic imaging, and pulse-inversion harmonic imaging.
    Kim AY; Choi BI; Kim TK; Kim KW; Lee JY; Han JK
    Invest Radiol; 2001 Oct; 36(10):582-8. PubMed ID: 11577268
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Mechanism of hepatic parenchyma-specific contrast of microbubble-based contrast agent for ultrasonography: microscopic studies in rat liver.
    Watanabe R; Matsumura M; Munemasa T; Fujimaki M; Suematsu M
    Invest Radiol; 2007 Sep; 42(9):643-51. PubMed ID: 17700280
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Vascular effects of microbubble-enhanced, pulsed, focused ultrasound on liver blood perfusion.
    Gao Y; Gao S; Zhao B; Zhao Y; Hua X; Tan K; Liu Z
    Ultrasound Med Biol; 2012 Jan; 38(1):91-8. PubMed ID: 22104531
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Ultrastructural and DNA damaging effects of lead nitrate in the liver.
    Narayana K; Al-Bader M
    Exp Toxicol Pathol; 2011 Jan; 63(1-2):43-51. PubMed ID: 19804962
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Preparation and characterization of a nanoscale ultrasound contrast agent.
    Wang D; Yang K; Gao YH; Tan KB; Liu Z
    Clin Imaging; 2010; 34(4):288-92. PubMed ID: 20630341
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Vascular effects induced by combined 1-MHz ultrasound and microbubble contrast agent treatments in vivo.
    Hwang JH; Brayman AA; Reidy MA; Matula TJ; Kimmey MB; Crum LA
    Ultrasound Med Biol; 2005 Apr; 31(4):553-64. PubMed ID: 15831334
    [TBL] [Abstract][Full Text] [Related]  

  • 32. X-ray contrast media induce aortic endothelial damage, which can be prevented with prior heparin treatment.
    Aliev G; Obrenovich ME; Seyidova D; Rzayev NM; Aliyev AS; Raina AK; Lamanna JC; Smith MA; Perry G
    J Submicrosc Cytol Pathol; 2003 Jul; 35(3):253-66. PubMed ID: 14690173
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Vascular lesions and s-thrombomodulin concentrations from auricular arteries of rabbits infused with microbubble contrast agent and exposed to pulsed ultrasound.
    Zachary JF; Blue JP; Miller RJ; O'Brien WD
    Ultrasound Med Biol; 2006 Nov; 32(11):1781-91. PubMed ID: 17112964
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Grey scale enhancement of rabbit liver and kidney by intravenous injection of a new lipid-coated ultrasound contrast agent.
    Liu P; Gao YH; Tan KB; Liu Z; Zuo S
    World J Gastroenterol; 2004 Aug; 10(16):2369-72. PubMed ID: 15285021
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Action of the chemical agent fipronil (active ingredient of acaricide Frontline®) on the liver of mice: an ultrastructural analysis.
    Ferreira M; De Oliveira PR; Denardi SE; Bechara GH; Mathias MI
    Microsc Res Tech; 2012 Feb; 75(2):197-205. PubMed ID: 21761502
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Preparation of polyelectrolyte multilayer film-coated microbubble ultrasound contrast agent].
    Xing ZW; Ke HT; Liu SQ; Dai ZF; Wang JR; Liu JB
    Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2008 Feb; 30(1):10-4. PubMed ID: 18361045
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Signal intensity of the liver parenchyma in microbubble contrast agent in the late liver phase reflects advanced fibrosis of the liver.
    Kaneko T; Teshigawara O; Sugimoto H; Hirota M; Inoue S; Takeda S; Nakao A
    Liver Int; 2005 Apr; 25(2):288-93. PubMed ID: 15780052
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Characterization of focal hepatic lesions in cirrhotic patients by Pulse Inversion Harmonic Imaging US contrast specific technique with Levovist.
    Quaia E; Forgács B; Calderan L; Bertolotto M; Pozzi Mucelli R
    Radiol Med; 2002 Oct; 104(4):285-94. PubMed ID: 12569309
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Ultrastructural dynamic observation on murine schistosomal hepatic fibrosis].
    Wang XL; Zhang LM; Tang FX; Guo ZW; Wu CY; Xiong ZJ
    Zhongguo Ji Sheng Chong Xue Yu Ji Sheng Chong Bing Za Zhi; 2002; 20(4):216-9. PubMed ID: 12568023
    [TBL] [Abstract][Full Text] [Related]  

  • 40. NTP technical report on the toxicity studies of Dibutyl Phthalate (CAS No. 84-74-2) Administered in Feed to F344/N Rats and B6C3F1 Mice.
    Marsman D
    Toxic Rep Ser; 1995 Apr; 30():1-G5. PubMed ID: 12209194
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.